Copay help by condition · Immune system, transplant and skin · read 2026-11-08
Ankylosing spondylitis (AS): which charitable copay funds are open
The one fund we hold for Ankylosing spondylitis is closed or at capacity right now (read 2026-11-08).
Funds fill and reopen. Use the alert below, ask the manufacturer's program for your drug (see the assistance finder), and check your state's Medicaid coverage.
If you have Medicare Part D: CMS prints the annual out-of-pocket threshold as $2,400 in 2027 ($2,100 in 2026) (Table V-2 of its CY 2027 announcement). It is a benefit parameter and applies to covered drugs under plan rules. What changes on January 1.
Swipe to read across
A copy for a patient, a clinic or a pharmacist, with each source and the date we read it.
Every fund we hold for Ankylosing spondylitis
- Closed or at capacityAnkylosing spondylitis (AS)
TotalAssist (Patient Advocate Foundation copay funds) ·
Award level: $4,400Insurance supported: Medicaid, Medicare, TRICARE
The page lists the fund as Closed. Source page
Drugs whose FDA label names Ankylosing spondylitis
9 drugs. Each row quotes the sentence of the drug's FDA label (Indications and Usage, openFDA) that names the condition. A label naming a condition is not a statement that the drug is approved, effective or covered for you. Dashes in quotes are shown as hyphens. Of these, 6 have a program (in our assistance finder or on the program's own page) and 1 has a Medicare negotiated price in the CMS file; an empty cell says we found nothing in our data, not that nothing exists.
| Drug | What the FDA label says | Manufacturer program | Medicare negotiated price |
|---|---|---|---|
| Enbrel Etanercept Every route for this drug | Ankylosing Spondylitis (AS) ( 1. Label on openFDA, read 2026-11-10 | Enbrel Support (via Amgen) RA Medication Assistance (Multiple Programs) Amgen Safety Net Foundation (program page) | $2,418.70 for a 30-day supply, effective 2027-01-01 |
| Cosentyx Secukinumab Every route for this drug | ... active ankylosing spondylitis (AS) in adults and pediatric patients 12 years of age and older. Label on openFDA, read 2026-11-10 | Cosentyx Connect (via Novartis) Limited Novartis Patient Assistance Foundation (NPAF) (program page) | selected by CMS for 2028; price not yet published |
| Xeljanz Tofacitinib Every route for this drug | Active ankylosing spondylitis (AS), who have had an inadequate response or intolerance to one or more TNF blockers. Label on openFDA, read 2026-11-10 | Pfizer RxPathways Limited no new patients starting July 1, 2026 RA Medication Assistance (Multiple Programs) | selected by CMS for 2028; price not yet published |
| Humira Adalimumab Every route for this drug | Ankylosing Spondylitis (AS) ( 1. Label on openFDA, read 2026-11-10 | Humira Complete (via myAbbVie Assist) myAbbVie Assist RA Medication Assistance (Multiple Programs) | not in the CMS negotiated-price file |
| Simponi Golimumab Every route for this drug | Adult patients with active Ankylosing Spondylitis (AS) ( 1. Label on openFDA, read 2026-11-10 | Johnson & Johnson Patient Assistance Program | not in the CMS negotiated-price file |
| Taltz Ixekizumab Every route for this drug | ... adults with active ankylosing spondylitis. Label on openFDA, read 2026-11-10 | Lilly Cares | not in the CMS negotiated-price file |
| Cimzia Certolizumab Pegol | Treatment of adults with active ankylosing spondylitis ( 1. Label on openFDA, read 2026-11-10 | not in our assistance finder | selected by CMS for 2028; price not yet published |
| Remicade Infliximab | Ankylosing Spondylitis : reducing signs and symptoms in adult patients with active disease. Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
1 drug whose label names more than 8 conditions
Broad labels, such as corticosteroids, list many conditions in one sentence. They are shown apart so they do not crowd the drugs written for Ankylosing spondylitis.
| Drug | What the FDA label says | Manufacturer program | Medicare negotiated price |
|---|---|---|---|
| Acthar Corticotropin | Ankylosing spondylitis; Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
Related conditions
No broader or more specific condition page for this one.
Group: Immune system, transplant and skin. All conditions: the condition index. Fund board for every condition: charitable copay fund status.
What changed
First read on 2026-11-08. We keep each read with its date, so a fund reopening or closing will show here as a change. Until we have a second read there is nothing to compare, and we do not guess. The read date of every source is on the changes page.
This page as data
The same facts as JSON, each fund with its source URL and read date: ankylosing-spondylitis.json. Edition 2026-11, root 006ab9a329709cbe. See the licence page.
Questions
Is there an open charitable copay fund for Ankylosing spondylitis?
As read on 2026-11-08, none of the 1 funds we hold for Ankylosing spondylitis say they are open. Funds reopen, so use the alert on this page.
Which organizations run funds for Ankylosing spondylitis?
TotalAssist (Patient Advocate Foundation copay funds). Each fund row on this page links to the organization's own page.
Does an open fund mean I qualify?
No. A status says whether a fund is taking applications. Eligibility, award level and which insurance it supports are each fund's own rules; where the page states them they are shown on the fund.
How current is this page?
Statuses are what each fund's own page said on the date we read it (2026-11-08). We do not promise a fund is still in that state today.